Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000819050-20-000048
Filing Date
2020-03-19
Accepted
2020-03-18 17:33:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A a20200318s3a.htm S-3/A 248441
2 EXHIBIT 23.1 a20200318s3aexhibit231.htm EX-23.1 3769
3 bbi_1a03.gif GRAPHIC 27959
  Complete submission text file 0000819050-20-000048.txt   291847
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-236757 | Film No.: 20725670
SIC: 2836 Biological Products, (No Diagnostic Substances)